Last reviewed · How we verify

NCT03548857: COPD

Muscle Function After Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status unknown Last updated 26 December 2019
What this trial tests

trial testing Lung transplantation in COPD in 20 participants. Status unknown.

Timeline
20 August 2018
Primary endpoint
30 April 2020
30 May 2020

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date20 August 2018
Primary completion30 April 2020
Estimated completion30 May 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 18 to 80, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the project is to investigate changes in the quadriceps muscle and cardiovascular regulation during exercise in relation to improved lung function after lung transplantation in patients with COPD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lung transplantation

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03548857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing